Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2022

Open Access 01-12-2022 | Spirometry | Research article

Relationship between concavity of the flow-volume loop and small airway measures in smokers with normal spirometry

Authors: Hooria Alowiwi, Stella Watson, Kanika Jetmalani, Cindy Thamrin, David P. Johns, E. Haydn Walters, Gregory G. King

Published in: BMC Pulmonary Medicine | Issue 1/2022

Login to get access

Abstract

Background

There is increasing evidence of small airway abnormalities in smokers despite normal spirometry. The concavity in the descending limb of the maximum expiratory flow curve (MEFV) is a recognised feature of obstruction and can provide information beyond FEV1, and potentially early smoking-related damage. We aimed to evaluate concavity measures compared to known small airway measurements.

Methods

Eighty smokers with normal spirometry had small airway function assessed: multiple breath nitrogen washout (MBNW) from which ventilation heterogeneity in the diffusion-dependent acinar (Sacin) and convection-dependent conductive (Scond) airways were assessed, and impulse oscillometry system (IOS) from which respiratory resistance and reactance at 5 Hz (R5 and X5) were measured. Concavity measures were calculated from the MEFV, partitioned into global and peripheral concavity.

Results

We found abnormal peripheral and global concavity as well as acinar ventilation heterogeneity are common in “normal” smokers. Concavity measures were not related to either MBNW or IOS measurements.

Conclusion

Abnormalities in concavity indices and MBNW or oscillometry parameters are common in smokers despite normal spirometry. However, these measures likely reflect different mechanisms of peripheral airway dysfunction.
Literature
1.
go back to reference Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology (Carlton, Vic). 2017;22(3):575–601.CrossRef Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Respirology (Carlton, Vic). 2017;22(3):575–601.CrossRef
2.
go back to reference Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–60.CrossRef Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–60.CrossRef
3.
go back to reference Johns DP, Das A, Toelle BG, Abramson MJ, Marks GB, Wood-Baker R, et al. Improved spirometric detection of small airway narrowing: concavity in the expiratory flow-volume curve in people aged over 40 years. Int J Chron Obstruct Pulmon Dis. 2017;12:3567–77.CrossRef Johns DP, Das A, Toelle BG, Abramson MJ, Marks GB, Wood-Baker R, et al. Improved spirometric detection of small airway narrowing: concavity in the expiratory flow-volume curve in people aged over 40 years. Int J Chron Obstruct Pulmon Dis. 2017;12:3567–77.CrossRef
4.
go back to reference Bhatawadekar SA, Leary D, de Lange V, Peters U, Fulton S, Hernandez P, et al. Reactance and elastance as measures of small airways response to bronchodilator in asthma. J Appl Physiol (1985). 2019;127(6):1772–81.CrossRef Bhatawadekar SA, Leary D, de Lange V, Peters U, Fulton S, Hernandez P, et al. Reactance and elastance as measures of small airways response to bronchodilator in asthma. J Appl Physiol (1985). 2019;127(6):1772–81.CrossRef
5.
go back to reference Jetmalani K, Thamrin C, Farah CS, Bertolin A, Chapman DG, Berend N, et al. Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry. Respirology. 2018;23(5):512–8.CrossRef Jetmalani K, Thamrin C, Farah CS, Bertolin A, Chapman DG, Berend N, et al. Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry. Respirology. 2018;23(5):512–8.CrossRef
6.
go back to reference Jetmalani K, Chapman DG, Thamrin C, Farah CS, Berend N, Salome CM, et al. Bronchodilator responsiveness of peripheral airways in smokers with normal spirometry. Respirology. 2016;21(7):1270–6.CrossRef Jetmalani K, Chapman DG, Thamrin C, Farah CS, Berend N, Salome CM, et al. Bronchodilator responsiveness of peripheral airways in smokers with normal spirometry. Respirology. 2016;21(7):1270–6.CrossRef
7.
go back to reference Oostveen E, Boda K, Van Der Grinten CPM, James AL, Young S, Nieland H, et al. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Eur Respir J. 2013;42(6):1513–23.CrossRef Oostveen E, Boda K, Van Der Grinten CPM, James AL, Young S, Nieland H, et al. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Eur Respir J. 2013;42(6):1513–23.CrossRef
8.
go back to reference Quanjer P, Stanojevic S, Cole T, Baur X, Hall GL, Culver B, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.CrossRef Quanjer P, Stanojevic S, Cole T, Baur X, Hall GL, Culver B, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–43.CrossRef
9.
go back to reference Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRef Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.CrossRef
10.
go back to reference Berend N, Woolcock AJ, Marlin GE. Correlation between the function and structure of the lung in smokers. Am Rev Respir Dis. 1979;119(5):695–705.PubMed Berend N, Woolcock AJ, Marlin GE. Correlation between the function and structure of the lung in smokers. Am Rev Respir Dis. 1979;119(5):695–705.PubMed
11.
go back to reference Mittman C, Edelman NH, Norris AH, Shock NW. Relationship between chest wall and pulmonary compliance and age. J Appl Physiol. 1965;20(6):1211–6.CrossRef Mittman C, Edelman NH, Norris AH, Shock NW. Relationship between chest wall and pulmonary compliance and age. J Appl Physiol. 1965;20(6):1211–6.CrossRef
12.
go back to reference Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med. 2004;170(4):414–9.CrossRef Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med. 2004;170(4):414–9.CrossRef
13.
go back to reference Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43(4):1051–8.CrossRef Quanjer PH, Weiner DJ, Pretto JJ, Brazzale DJ, Boros PW. Measurement of FEF25-75% and FEF75% does not contribute to clinical decision making. Eur Respir J. 2014;43(4):1051–8.CrossRef
14.
go back to reference Kwon DS, Choi YJ, Kim TH, Byun MK, Cho JH, Kim HJ, et al. FEF25–75% values in patients with normal lung function can predict the development of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2913–21.CrossRef Kwon DS, Choi YJ, Kim TH, Byun MK, Cho JH, Kim HJ, et al. FEF25–75% values in patients with normal lung function can predict the development of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:2913–21.CrossRef
15.
go back to reference Wafy S, Agamy G, Ali A. Early spirometric changes in asymptomatic smokers; is it a time dependent? Eur Respir J. 2016;48(suppl 60):PA4320. Wafy S, Agamy G, Ali A. Early spirometric changes in asymptomatic smokers; is it a time dependent? Eur Respir J. 2016;48(suppl 60):PA4320.
16.
go back to reference Hoesein FAAM, Jong PAD, Lammers JWJ, Mali WP, Schmidt M, Koning HJD, et al. Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation. Eur Respir J. 2015;45(3):644–51.CrossRef Hoesein FAAM, Jong PAD, Lammers JWJ, Mali WP, Schmidt M, Koning HJD, et al. Airway wall thickness associated with forced expiratory volume in 1 second decline and development of airflow limitation. Eur Respir J. 2015;45(3):644–51.CrossRef
17.
go back to reference Zaigham S, Wollmer P, Engström G. The Association of lung clearance index with COPD and FEV(1) Reduction in “Men Born in 1914.” COPD. 2017;14(3):324–9.CrossRef Zaigham S, Wollmer P, Engström G. The Association of lung clearance index with COPD and FEV(1) Reduction in “Men Born in 1914.” COPD. 2017;14(3):324–9.CrossRef
Metadata
Title
Relationship between concavity of the flow-volume loop and small airway measures in smokers with normal spirometry
Authors
Hooria Alowiwi
Stella Watson
Kanika Jetmalani
Cindy Thamrin
David P. Johns
E. Haydn Walters
Gregory G. King
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2022
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-022-01998-w

Other articles of this Issue 1/2022

BMC Pulmonary Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.